INS and Hypoglycemia: It is, however, important to note thatrandomized clinical trials are generally conducted in low-risk populations and risk ofhypoglycemia may be higher in the real world and that recurrence may not necessarily bedirectly due to the insulin itself but rather to other underlying medical conditions,errors with dosing, dietary noncompliance, or not following hypoglycemia managementinstructions.